SEC Form 4 · Insider disclosures

Recent Insider Buying

Recent purchases grouped by company. A P-code purchase may be open-market or private; check the filing for context.

Updates delayedUpdated Some disclosures are unavailable

Purchase rows791
Sale rows3,373
Purchase value (USD)US$649.43M
Sale value (USD)US$72.39B

Recent company disclosures

284 companies · 791 rows
VNDA

Vanda Pharmaceuticals Inc.

Purchase total ≈ US$38.09K

3 transaction rows · 1 filings

Duncan Charles Cliff

Purchase
Director disclosed purchase of 750 shares

Filing did not check the 10b5-1 plan indicator

Approximately 99.5K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.85K

Duncan Charles Cliff

Purchase
Director disclosed purchase of 3,447 shares

Filing did not check the 10b5-1 plan indicator

Approximately 103K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$13.17K
Show 1 more transaction rows

Duncan Charles Cliff

Purchase
Director disclosed purchase of 5,803 shares

Filing did not check the 10b5-1 plan indicator

Approximately 109K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$22.08K
CLX

CLOROX CO /DE/

Purchase total ≈ US$400.25K

1 transaction rows · 1 filings

Breber Pierre R

Purchase
Director disclosed purchase of 4,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 22.22%; approximately 22K shares afterward

Calculated transaction value approximately US$400.25K
PLSM

Pulsenmore Ltd.

Purchase total ≈ US$15.74K

1 transaction rows · 1 filings

Sonnenschein Elazar

Purchase
CEO / Director disclosed purchase of 9,259 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 1.04%; approximately 892K shares afterward

Calculated transaction value approximately US$15.74K
JBSS

SANFILIPPO JOHN B & SON INC

Purchase total ≈ US$27.59K

3 transaction rows · 2 filings

Finn Michael J

Purchase
Officer disclosed purchase of 200 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 2.82%; approximately 7.28K shares afterward

Calculated transaction value approximately US$11.22K

Finn Michael J

Purchase
Officer disclosed purchase of 200 shares

Filing did not check the 10b5-1 plan indicator

Approximately 6.98K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$10.91K
Show 1 more transaction rows

Finn Michael J

Purchase
Officer disclosed purchase of 100 shares

Filing did not check the 10b5-1 plan indicator

Approximately 7.08K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$5.46K
BKR

Baker Hughes Co

Purchase total ≈ US$531K

1 transaction rows · 1 filings

RICE JOHN G

Purchase
Director disclosed purchase of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 14.85%; approximately 77.3K shares afterward

Calculated transaction value approximately US$531K
AOMR

Angel Oak Mortgage REIT, Inc.

Purchase total ≈ US$46.47K

1 transaction rows · 1 filings

Parsons Landon

Purchase
Director disclosed purchase of 7,400 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 14.84%; approximately 57.2K shares afterward

Calculated transaction value approximately US$46.47K
OACOX

OneAscent Capital Opportunities Fund

Purchase total ≈ US$288.25K

1 transaction rows · 1 filings

Siverling John

Purchase
Reporting owner disclosed purchase of 25,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 4.65K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$288.25K
CIVB

CIVISTA BANCSHARES, INC.

Purchase total ≈ US$6.06K

1 transaction rows · 1 filings

Macioce Mark J.

Purchase
Director disclosed purchase of 209 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 62.88%; approximately 541 shares afterward

Calculated transaction value approximately US$6.06K
XIVYX

Institutional Investment Strategy Fund

Purchase total ≈ US$101

1 transaction rows · 1 filings

Ghodoosi Arash

Purchase
Officer disclosed purchase of 7.692 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.01%; approximately 41.7K shares afterward

Calculated transaction value approximately US$101
RRBI

RED RIVER BANCSHARES INC

Purchase total ≈ US$112.61K

3 transaction rows · 1 filings

Price Teddy Ray

Purchase
Director disclosed purchase of 878 shares

Filing did not check the 10b5-1 plan indicator

Approximately 379K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$94.64K

Price Teddy Ray

Purchase
Director disclosed purchase of 153 shares

Filing did not check the 10b5-1 plan indicator

Approximately 66.1K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$16.46K
Show 1 more transaction rows

Price Teddy Ray

Purchase
Director disclosed purchase of 14 shares

Filing did not check the 10b5-1 plan indicator

Approximately 6.15K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.51K
ASPE

Aspen Neuroscience, Inc.

Purchase total ≈ US$30M

2 transaction rows · 2 filings

Thompson Peter A.

Purchase
Director / 10% owner disclosed purchase of 1,000,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 3.59M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$15M

ORBIMED ADVISORS LLC / OrbiMed Capital GP VII LLC

Purchase
Director / 10% owner disclosed purchase of 1,000,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 3.59M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$15M
LYCA

Lycia Therapeutics, Inc.

Purchase total ≈ US$223.82K

1 transaction rows · 1 filings

Venrock Healthcare Capital Partners III, L.P. / VHCP Co-Investment Holdings III, LLC / VHCP Management III, LLC / Venrock Healthcare Capital Partners EG, L.P. / VHCP Management EG, LLC / Venrock Healthcare Capital Partners XP, L.P. / VHCP Management XP, LLC / Koh Bong Y / Shah Nimish P

Purchase
10% owner disclosed purchase of 8,305 shares

Filing did not check the 10b5-1 plan indicator

Approximately 6.86M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$223.82K
Sources, coverage & updates
SEC filing dates: 2026-11-04 — 2026-11-13 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Nov 11, 7:34 PM ET

Partial coverage; backfill in progress

Discovered filings 3,950 · Parsed 3,950 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 95 unavailable, unverified or non-USD amounts are excluded. 1836 filings · 1788 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗